Abstract:Introduction: Triple-negative breast cancer (TNBC) represents a significant global health crisis due to its resistance to conventional therapies and lack of specific molecular targets. This study explored the potential of Eriocephalus racemosus (E. racemosus) as an alternative treatment for TNBC. The cytotoxic properties and high-resolution respirometry mitochondrial activities of E. racemosus against the MDA-MB 231 TNBC cell line were evaluated. Methods: Hexane solvent and bioactive fraction extractions of E. racemosus were performed, while mass spectrometry-based metabolite profiling was used to identify the phytochemical constituents of the extracts. The extracts were further tested against MDA-MB 231 TNBC cells to determine their cytotoxicity. The mode of cell death was determined using flow cytometry. The activities of caspases 3, 8, and 9 were assessed using a multiplex activity assay kit. Glycolytic activity and High-resolution respirometry measurements of mitochondrial function in the MDA-MB 231 cell line were conducted using the Seahorse XFp and Oroboros O2K. Results: Metabolite profiling of E. racemosus plant crude extracts identified the presence of coumarins, flavonoids, sesquiterpenoids, triterpenoids, and unknown compounds. The extracts demonstrated promising cytotoxic activities, with a half maximal inhibitory concentration (IC50) of 12.84 µg/mL for the crude hexane extract and 15.49 µg/mL for the bioactive fraction. Further, the crude hexane and bioactive fraction extracts induced apoptosis in the MDA-MB-231 TNBC cells, like the reference drug cisplatin (17.44%, 17.26% and 20.25%, respectively) compared to untreated cells. Caspase 3 activities confirmed the induction of apoptosis in both cisplatin and the plant crude extracts, while caspase 8 and 9 activities confirmed the activation of both the intrinsic and extrinsic apoptosis pathways. Increased levels of glycolytic activity were observed in the hexane crude extract. High-resolution respiratory measurements showed elevated mitochondrial activities in all mitochondrial states except for complex-IV activity. Conclusion: These findings support further exploration of E. racemosus as a potential therapeutic agent for TNBC, offering a promising avenue for the development of targeted treatments with minimal adverse effects.

Precise Discovery of a STAT3 Inhibitor from Eupatorium Lindleyanum and Evaluation of Its Activity of Anti-Triple-negative Breast Cancer

Eupalinolide J Inhibits Cancer Metastasis by Promoting STAT3 Ubiquitin-Dependent Degradation

Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells Via Targeting STAT3 Signaling Pathway

Identification of Marine Natural Product Pretrichodermamide B As a STAT3 Inhibitor for Efficient Anticancer Therapy

Eucannabinolide, a Novel Sesquiterpene Lactone, Suppresses the Growth, Metastasis and BCSCS-like Traits of TNBC Via Inactivation of STAT3

Eupalinolide N, a Previously Undescribed Sesquiterpene Lactone with Anti-inflammatory Activity from Eupatorium Lindleyanum

Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer

Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition

Eupalinolide J Induces Apoptosis, Cell Cycle Arrest, Mitochondrial Membrane Potential Disruption and DNA Damage in Human Prostate Cancer Cells.

Research and development of erythroblastine A as a STAT3 inhibitor of lead compound and its application in tumor therapy

Targeting Pharmacophore with Probe-Reactivity-guided Fractionation to Precisely Identify Electrophilic Sesquiterpenes and Its Activity of Anti-Tnbc

Identification of novel STAT3 inhibitors bearing 2-acetyl-7-phenylamino benzofuran scaffold for antitumour study

Eupalinolide O, a Novel Sesquiterpene Lactone from Eupatorium Lindleyanum DC., Induces Cell Cycle Arrest and Apoptosis in Human MDA-MB-468 Breast Cancer Cells.

A New Sesquiterpene Lactone from<i>Eupatorium chinense</i>and its Anti-TNBC Activity

Cytotoxic properties, glycolytic effects and high-resolution respirometry mitochondrial activities of Eriocephalus racemosus against MDA-MB 231 triple-negative breast cancer

Identification of New Shikonin Derivatives As Antitumor Agents Targeting Stat3 Sh2 Domain

Discovery of a pimaradiene that decreases viability of MDA‐MB‐468 cells through inhibition of EGFR signaling pathway

Retraction Note To: A New Synthetic Derivative of Cryptotanshinone KYZ3 As STAT3 Inhibitor for Triple-Negative Breast Cancer Therapy

Structure-based Discovery of Potent and Selective Small-Molecule Inhibitors Targeting Signal Transducer and Activator of Transcription 3 (STAT3).

Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer

Design, Synthesis and Biological Evaluation of Benzyloxyphenyl-Methylaminophenol Derivatives As STAT3 Signaling Pathway Inhibitors.